Prognostic Markers and Trials in Penile Cancer.
- Resource Type
- Article
- Authors
- Naushad, Naufal; Deb, Abdalla A.; Agag, Ayman A.; Serag, Hosam A.; Sangar, Vijay K.
- Source
- Urology Research & Practice. May2023, Vol. 49 Issue 3, p138-146. 9p.
- Subject
- *C-reactive protein
*PAPILLOMAVIRUSES
*PENILE tumors
*GENETICS
*ONCOGENES
*CANCER chemotherapy
*LYMPH nodes
*METASTASIS
*CANCER patients
*CHEMORADIOTHERAPY
*GLYCOPROTEINS
*TUMOR suppressor genes
*TUMOR markers
*RADIOTHERAPY
*SQUAMOUS cell carcinoma
*ANTIGENS
- Language
- ISSN
- 2980-1478
New tumor biomarkers open the potential for designing personalized therapy for penile squamous cell carcinoma. Despite the initial promising results of some biomarkers, controversy remains due to contradictory studies. Further robust research work is required before incorporating biomarkers in the personalized management of penile cancer. This narrative review aims to highlight some of the most commonly and recently investigated biomarkers of penile cancer and to summarize the ongoing registered clinical trials for the management of penile cancer patients. [ABSTRACT FROM AUTHOR]